Figures computed from official regulatory filings — .
Ownershipinsiders 34.96% · institutions 0%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for MARIZYME, INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Marizyme, Inc., a multi-technology life science company, engages in the research, manufacture, and commercialization of medical devices, diagnostics, and products to address clinical needs in the United States, Europe, and Asia. The company operates as a medical technology company that delivers solutions for coronary artery bypass graft surgery. Its product portfolio includes DuraGraft, a biocompatible intraoperative vascular graft storage and flushing solution; and Krillase, an enzyme that acts to break protein bonds and has applications in wound debridement, wound healing, and dental care and thrombosi, as well as MATLOC 1, a lab on chip digital device, which is under development for screening of individuals at risk for the development of chronic kidney disease. The company also engages in the development of MAR-FG-001, a fat grafting technology for fat grafting procedures. The company was formerly known as GBS Enterprises Incorporated and changed its name to Marizyme, Inc. in March 2018. The company was incorporated in 2007 and is based in Jupiter, Florida.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
16 buys10 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Braeden Lichti | Other | $381.5K | SEC | ||
| OtherD (derivative) |
| n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) |
| SEC |
| Braeden Lichti | Sell | $9.7K | SEC |
| Braeden Lichti | Sell | $17.9K | SEC |
| Braeden Lichti | Sell | $9.6K | SEC |
| Braeden Lichti | Buy | $17.9K | conv 35 | SEC |
| Braeden Lichti | Buy | $9.6K | conv 66First in 12mo | SEC |
| Braeden Lichti | Buy | $9.7K | conv 55 | SEC |
| Dhaduk Vithalbhai D | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dhaduk Vithalbhai D | Award | $106.4K | Unusual size | SEC |
| Dhaduk Vithalbhai D | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | Unusual size | SEC |
| Dhaduk Vithalbhai D | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | Unusual size | SEC |
| Kampf Julie B. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dhaduk Vithalbhai D | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hearl William | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| STEWART MICHAEL R | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Brostowin Terry A | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hearl William | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ross Harrison | AwardD (derivative) | $24.6K | SEC |
| Kovalyov Georgiy | AwardD (derivative) | $24.6K | SEC |
| Barthel David | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Barthel David | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Brostowin Terry A | AwardD (derivative) | $156.3K | SEC |
| SAPIRSTEIN JAMES | AwardD (derivative) | $156.3K | Unusual size | SEC |
| Harmon Bruce | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |